Jesper Bonde
www.hvh-mpl.dk
0000-0003-4853-6747
Hvidovre Hospital
34 papers found
Refreshing results…
Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study
Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark – The SHADE cohort study
Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30years
Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions
Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: A split-sample study
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
Cervical cancer screening at crossroads
Comparison of the immunogenicity of Cervarix(®) and Gardasil(®) human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33 and HPV-45 in HIV-infected adults.
Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies
Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
Comparison of the Immunogenicity and Reactogenicity of Cervarix and Gardasil Human Papillomavirus Vaccines in HIV-Infected Adults: A Randomized, Double-Blind Clinical Trial
Prevalence of Human Papillomavirus Infection in Unselected SurePath Samples Using the APTIMA HPV mRNA Assay
Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark
No increased sperm DNA fragmentation index in semen containing human papillomavirus or herpesvirus
The stem cell marker CD133 is highly expressed in sessile serrated adenoma and its borderline variant compared with hyperplastic polyp
Clinical Validation of the BD Onclarity™ HPV Assay Using a Non-Inferiority Test
Human Herpesvirus-6A/B Binds to Spermatozoa Acrosome and Is the Most Prevalent Herpesvirus in Semen from Sperm Donors
Missing publications? Search for publications with a matching author name.